Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

SHA:688639 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,123	1,805	1,704	1,220	841.86	466.43
Other Revenue	527.91	372.99	234.23	198.65	112.23	20.82
Revenue	2,651	2,178	1,938	1,419	954.1	487.24
Revenue Growth (YoY)	25.96%	12.37%	36.63%	48.69%	95.81%	-0.83%
Cost of Revenue	2,082	1,638	1,156	870.26	646	289.4
Gross Profit	568.43	539.66	782.37	548.39	308.1	197.85
Selling, General & Admin	261.32	221.48	172.08	142.22	79.93	42.76
Research & Development	129.37	124.05	108.82	78.61	52.84	30.12
Other Operating Expenses	-1.2	-13.41	4.55	7.97	6.58	6.32
Operating Expenses	392.99	330.9	285.77	231.29	139.03	79.4
Operating Income	175.43	208.75	496.6	317.1	169.06	118.45
Interest Expense	-41.72	-37.87	-10.64	-0.54	-1.11	-2.83
Interest & Investment Income	6.95	5.25	5.91	10.64	7.5	0.33
Currency Exchange Gain (Loss)	8.05	14.04	7.06	5.43	-0.16	-4.37
Other Non Operating Income (Expenses)	-4.38	-3.3	-2.66	-0.59	-0.39	-0.29
EBT Excluding Unusual Items	144.34	186.87	496.27	332.04	174.91	111.3
Gain (Loss) on Sale of Investments	-1.49	-	-0.31	-0.75	1.06	-
Gain (Loss) on Sale of Assets	-1.5	-0.37	-2.67	-4.62	-0.36	-0.3
Asset Writedown	-	-	-	-	-5.61	-
Other Unusual Items	14.13	14.9	12.98	16.32	20.78	28.94
Pretax Income	155.48	201.41	506.27	342.98	190.79	139.94
Income Tax Expense	9.77	16.85	59.67	23.64	22.55	18.84
Earnings From Continuing Operations	145.71	184.56	446.6	319.34	168.24	121.1
Minority Interest in Earnings	8.99	4.96	2.46	0.69	-	-
Net Income	154.7	189.52	449.06	320.03	168.24	121.1
Net Income to Common	154.7	189.52	449.06	320.03	168.24	121.1
Net Income Growth	-62.04%	-57.80%	40.32%	90.23%	38.92%	-4.18%
Shares Outstanding (Basic)	243	231	229	227	208	170
Shares Outstanding (Diluted)	243	231	229	227	208	170
Shares Change (YoY)	5.99%	0.88%	0.72%	9.33%	22.57%	-0.34%
EPS (Basic)	0.64	0.82	1.96	1.41	0.81	0.71
EPS (Diluted)	0.64	0.82	1.96	1.41	0.81	0.71
EPS Growth	-64.18%	-58.16%	39.31%	73.99%	13.35%	-3.85%
Free Cash Flow	-549.44	-723.72	-967.75	-98.92	-84.93	36.93
Free Cash Flow Per Share	-2.27	-3.13	-4.22	-0.43	-0.41	0.22
Dividend Per Share	0.250	0.250	0.621	0.428	0.262	0.160
Dividend Growth	-59.72%	-59.72%	44.99%	63.33%	63.51%	-
Gross Margin	21.44%	24.78%	40.36%	38.66%	32.29%	40.61%
Operating Margin	6.62%	9.59%	25.62%	22.35%	17.72%	24.31%
Profit Margin	5.84%	8.70%	23.17%	22.56%	17.63%	24.85%
Free Cash Flow Margin	-20.73%	-33.23%	-49.93%	-6.97%	-8.90%	7.58%
EBITDA	341.24	347.41	595.44	376.25	216.56	153.49
EBITDA Margin	12.87%	15.95%	30.72%	26.52%	22.70%	31.50%
D&A For EBITDA	165.8	138.66	98.84	59.15	47.5	35.04
EBIT	175.43	208.75	496.6	317.1	169.06	118.45
EBIT Margin	6.62%	9.59%	25.62%	22.35%	17.72%	24.31%
Effective Tax Rate	6.28%	8.37%	11.79%	6.89%	11.82%	13.46%
Revenue as Reported	2,651	2,178	1,938	1,419	954.1	487.24
Advertising Expenses	-	4.84	3.33	1.33	0.7	0.37

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.